These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33514512)

  • 1. NK Cell-Derived IL-10 Supports Host Survival during Sepsis.
    Jensen IJ; McGonagill PW; Butler NS; Harty JT; Griffith TS; Badovinac VP
    J Immunol; 2021 Mar; 206(6):1171-1180. PubMed ID: 33514512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of IL-10 restores the downregulation of IL-18 receptor on natural killer cells and interferon-γ production in septic mice, thus leading to an improved survival.
    Hiraki S; Ono S; Kinoshita M; Tsujimoto H; Takahata R; Miyazaki H; Saitoh D; Seki S; Hase K
    Shock; 2012 Feb; 37(2):177-82. PubMed ID: 22089189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK Cell IL-10 Production Requires IL-15 and IL-10 Driven STAT3 Activation.
    Clark SE; Burrack KS; Jameson SC; Hamilton SE; Lenz LL
    Front Immunol; 2019; 10():2087. PubMed ID: 31552035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections.
    Jensen IJ; Winborn CS; Fosdick MG; Shao P; Tremblay MM; Shan Q; Tripathy SK; Snyder CM; Xue HH; Griffith TS; Houtman JC; Badovinac VP
    PLoS Pathog; 2018 Oct; 14(10):e1007405. PubMed ID: 30379932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of IL-10-Producing Natural Killer Cells in the Regulatory Mechanisms of Inflammation during Systemic Infection.
    Martinez-Espinosa I; Serrato JA; Ortiz-Quintero B
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of NK cell and monocyte receptors in critically ill patients--potential biomarkers of sepsis.
    Kjaergaard AG; Nielsen JS; Tønnesen E; Krog J
    Scand J Immunol; 2015 Apr; 81(4):249-58. PubMed ID: 25619264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating growth/differentiation factor 15 is associated with human CD56
    Kleinertz H; Hepner-Schefczyk M; Ehnert S; Claus M; Halbgebauer R; Boller L; Huber-Lang M; Cinelli P; Kirschning C; Flohé S; Sander A; Waydhas C; Vonderhagen S; Jäger M; Dudda M; Watzl C; Flohé SB
    EBioMedicine; 2019 May; 43():380-391. PubMed ID: 30992245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with Recombinant Interleukin-15 (IL-15) Increases the Number of T Cells and Natural Killer (NK) Cells and Levels of Interferon-γ (IFN-γ) in a Rat Model of Sepsis.
    Zhao X; Qi H; Zhou J; Xu S; Gao Y
    Med Sci Monit; 2019 Jun; 25():4450-4456. PubMed ID: 31201735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-15-induced IL-10 increases the cytolytic activity of human natural killer cells.
    Park JY; Lee SH; Yoon SR; Park YJ; Jung H; Kim TD; Choi I
    Mol Cells; 2011 Sep; 32(3):265-72. PubMed ID: 21809216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Critical Blimp-1-Dependent IL-10 Regulatory Pathway in T Cells Protects From a Lethal Pro-inflammatory Cytokine Storm During Acute Experimental
    De Trez C; Stijlemans B; Bockstal V; Cnops J; Korf H; Van Snick J; Caljon G; Muraille E; Humphreys IR; Boon L; Van Ginderachter JA; Magez S
    Front Immunol; 2020; 11():1085. PubMed ID: 32655552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of CD1d activation suppresses septic mortality: a role for NK-T cells in septic immune dysfunction.
    Rhee RJ; Carlton S; Lomas JL; Lane C; Brossay L; Cioffi WG; Ayala A
    J Surg Res; 2003 Nov; 115(1):74-81. PubMed ID: 14572776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection.
    Scott MJ; Hoth JJ; Turina M; Woods DR; Cheadle WG
    Cytokine; 2006 Jan; 33(2):79-86. PubMed ID: 16488621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-15 Enables Septic Shock by Maintaining NK Cell Integrity and Function.
    Guo Y; Luan L; Patil NK; Wang J; Bohannon JK; Rabacal W; Fensterheim BA; Hernandez A; Sherwood ER
    J Immunol; 2017 Feb; 198(3):1320-1333. PubMed ID: 28031340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors expression and interferon-γ production by NK cells in human sepsis.
    Souza-Fonseca-Guimaraes F; Parlato M; Philippart F; Misset B; Cavaillon JM; Adib-Conquy M;
    Crit Care; 2012 Oct; 16(5):R206. PubMed ID: 23098236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype and functions of natural killer cells in critically-ill septic patients.
    Forel JM; Chiche L; Thomas G; Mancini J; Farnarier C; Cognet C; Guervilly C; Daumas A; Vély F; Xéridat F; Vivier E; Papazian L
    PLoS One; 2012; 7(12):e50446. PubMed ID: 23236375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
    Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
    J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenotype and functions of natural killer cells in septic patients and its clinical significance].
    Pan A; Deng Y; Yang T; Zhang L; Shao M; Zhou S; Wang C; Liu B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Nov; 26(11):827-31. PubMed ID: 25399899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biology of natural killer cells during sepsis.
    Guo Y; Patil NK; Luan L; Bohannon JK; Sherwood ER
    Immunology; 2018 Feb; 153(2):190-202. PubMed ID: 29064085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells.
    Yu J; Wei M; Becknell B; Trotta R; Liu S; Boyd Z; Jaung MS; Blaser BW; Sun J; Benson DM; Mao H; Yokohama A; Bhatt D; Shen L; Davuluri R; Weinstein M; Marcucci G; Caligiuri MA
    Immunity; 2006 May; 24(5):575-90. PubMed ID: 16713975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
    Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
    Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.